Overview
Sleep wake disturbances compound recovery in over half of pediatric traumatic brain injury survivors, leading to impaired quality of life, and few effective interventions exist to treat this important morbidity. Therefore, this study will conduct a randomized controlled trial evaluating a melatonin intervention started during hospitalization and continued after discharge compared to placebo. The trial will investigate if this intervention is feasible, acceptable, and effective at reducing sleep wake disturbances as measured on the Sleep Disturbances Scale for Children 1-month after hospital discharge.
Participants will be randomly assigned to receive the intervention (melatonin) or to the control group (placebo) with a goal of equal numbers of participants in each group and all will receive sleep education. Participants will be followed closely after consent and outcomes will be assessed at hospital discharge, and 1-month. Outcomes will focus on feasibility (ability to recruit patients into the trial) and acceptability (patient safety and satisfaction), but will also assess the effectiveness of the intervention to reduce sleep disturbances after discharge. The investigators will assess sleep using questionnaires and actigraphy (watch-like activity monitors). Exploratory outcomes will include global health outcomes.
Eligibility
- Inclusion
-
- Children age ≥6 years and <19 years
- Traumatic brain injury defined as disruption of the normal function of the brain resulting from blunt force injury with a severity defined as mild complicated, moderate, or severe by the Glasgow Coma Scale with the presence of intracranial injury on imaging
- Admission to Oregon Health & Science University Hospitals
- Deemed likely to survive hospitalization by clinical care team
- Able to tolerate enteral medications within 72 hours of admission
- Child participant resides with parent or legal guardian
- Exclusion
- Lack stable means of communication with study team (phone, email, mailing address)
- Abusive trauma suspected or confirmed
- Dialysis
- Extracorporeal support (e.g. ECMO)
- Significant liver injury defined as >2x normal levels for AST or ALT
- Clinical team safety concerns with use of intervention
- Pregnancy
- Prisoners